作者：
Gilmour, Gary [1]
;
Porcelli, Stefano [2]
;
Bertaina-Anglade, Valerie [3]
;
Arce, Estibaliz [4]
;
Dukart, Juergen [5]
;
Hayen, Anja [6]
;
Lobo, Antonio [7]
;
Lopez-Anton, Raul [8]
;
Pich, Emilio Merlo [9]
;
Pemberton, Darrel J. [10]
;
Havenith, Martha N. [11]
;
Glennon, Jeffrey C. ;
Harel, Brian T. ;
Dawson, Gerard ;
Marston, Hugh ;
Kozak, Rouba ;
Serretti, Alessandro
作者单位：
Pfizer Inc, Worldwide Res & Dev, Early Clin Dev, New York, NY USA
[1]
Eli Lilly & Co Ltd, Translat Neurosci, Sunninghill Rd, Windlesham GU20 6PH, Surrey, England
[2]
IIS Aragon, Zaragoza, Spain
[3]
P1vital Ltd, Wallingford, Oxon, England
[4]
Univ Bologna, Dept Biomed & NeuroMotor Sci, Bologna, Italy
[5]
Univ Zaragoza, Dept Med & Psychiat, Zaragoza, Spain
[6]
Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[7]
Janssen Res & Dev, Beerse, Belgium
[8]
F Hoffmann La Roche, Pharma Res Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland
[9]
Takeda Dev Ctr Europe, CNS Therapeut Area Unit, London, England
[10]
Biotrial, CS 34246, 7-9 Rue Jean Louis Bertrand, F-35042 Rennes, France
[11]
发布时间
2019-09-17
换一批
换一批
